126 related articles for article (PubMed ID: 8375257)
1. Effect of pancreatic elastase on diabetic nephropathy.
Nagai T; Tomizawa T; Mori M
Diabetes Care; 1993 Aug; 16(8):1214-5. PubMed ID: 8375257
[No Abstract] [Full Text] [Related]
2. The effect of pancreatic elastase on diabetic nephropathy.
Nagai T
Diabetes Res Clin Pract; 1994 Jul; 24(3):161-5. PubMed ID: 7988347
[TBL] [Abstract][Full Text] [Related]
3. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.
Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M
J Diabetes Complications; 1994; 8(1):13-7. PubMed ID: 8167381
[TBL] [Abstract][Full Text] [Related]
4. Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.
Christensen PK; Rossing P; Nielsen FS; Parving HH
Diabet Med; 1999 May; 16(5):388-94. PubMed ID: 10342338
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of proteinuria in diabetic patients with nephropathy].
Satoh K
Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):905-12. PubMed ID: 2794672
[No Abstract] [Full Text] [Related]
6. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
[TBL] [Abstract][Full Text] [Related]
7. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
Imano E; Kanda T; Nakatani Y; Nishida T; Arai K; Motomura M; Kajimoto Y; Yamasaki Y; Hori M
Diabetes Care; 1998 Dec; 21(12):2135-9. PubMed ID: 9839106
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of alacepril, a new angiotensin-converting enzyme inhibitor on albuminuria and glycemic state: an open multicenter trial. Alacepril Study Group.
Utsunomiya K; Ikeda Y
J Diabet Complications; 1991; 5(2-3):165-6. PubMed ID: 1770032
[TBL] [Abstract][Full Text] [Related]
9. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension.
Ohno T; Kato N; Shimizu M; Ishii C; Ito Y; Tomono S; Kawazu S; Murata K
Diabetes Res; 1993; 22(3):115-21. PubMed ID: 8076444
[TBL] [Abstract][Full Text] [Related]
10. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
[TBL] [Abstract][Full Text] [Related]
11. Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
Cohen MP; Lautenslager GT; Shearman CW
Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754
[TBL] [Abstract][Full Text] [Related]
12. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
Diabetes Care; 2000 Aug; 23(8):1168-71. PubMed ID: 10937516
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
14. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
[TBL] [Abstract][Full Text] [Related]
15. Glycaemic control and progression of nephropathy in proteinuric NIDDM patients.
Baba T; Tomiyama T; Kodama T; Murabayashi S
Diabetes Res Clin Pract; 1992 May; 16(2):157-9. PubMed ID: 1600855
[No Abstract] [Full Text] [Related]
16. Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study.
Hu Y; Shi R; Mo R; Hu F
Aging (Albany NY); 2020 Jun; 12(11):10317-10336. PubMed ID: 32484786
[TBL] [Abstract][Full Text] [Related]
17. Effect of urokinase on preservation of renal function in patients with diabetic nephropathy.
Sakai H; Watanabe S; Inoue I; Tanaka K; Yagame M; Machimura H; Kaneshige H; Nomoto Y
J Diabet Complications; 1991; 5(2-3):95-7. PubMed ID: 1770066
[TBL] [Abstract][Full Text] [Related]
18. Renal function in non-insulin-dependent diabetes mellitus: purposes and design of the Diabetic Renal Disease Study.
Nelson RG
Acta Diabetol; 1991; 28(2):143-50. PubMed ID: 1777650
[TBL] [Abstract][Full Text] [Related]
19. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
[TBL] [Abstract][Full Text] [Related]
20. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.
Chan JC; Cheung CK; Cheung MY; Swaminathan R; Critchley JA; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1013-6. PubMed ID: 7555533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
